Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-01

Clinical Trial Update: A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability, and pharmacokinetics/pharmacodynamics study of HEC169584 capsules in healthy subjects. The trial lists Nonalcoholic steatohepatiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEC169584

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Non - Alcoholic Steatohepatitis | Phase 1 | Status: NOT_YET_RECRUITING